#Japan #Tokyo #Sony Group #Qoli #Micro-Surgery

Qoli's Groundbreaking Fundraising for Micro-Surgery

In a significant development for the field of surgical robotics, Qoli Inc. has announced the successful completion of its Series A fundraising round, securing a total of 1.8 billion yen. This remarkable achievement sees Qoli partnering with prominent investors including Fast Track Initiative (FTI) and MedVenture Partners, alongside backing from Sony Group and the Development Bank of Japan (DBJ). This influx of capital positions Qoli to drive forward its mission: pioneering innovative robotic solutions for enhancing micro-surgery procedures.

The Importance of Micro-Surgery

Micro-surgery, a specialized area within surgical practice that involves intricate operations on minute structures like blood vessels and nerves under magnification, plays an essential role in not only saving lives but also in improving the quality of life (QOL) for patients. Despite its critical importance, the practice requires a high degree of skill, expertise, and significant training, which limits the number of surgeons capable of performing such specialized procedures. Qoli aims to address this gap by leveraging advanced robotic technologies to support surgeons and make these complex surgeries more accessible and safer.

Innovative Solutions for Health

With the additional funding, Qoli is committed to developing advanced robotic products and solutions designed specifically for micro-surgery. By incorporating technologies cultivated through Sony's research in medical robotics, Qoli aims to create precision and safe robotic assistance that can be integrated into clinical practices. These developments will enhance surgeons’ capabilities, thereby enabling a wider range of healthcare professionals to undertake micro-surgery tasks with confidence and skill.

Qoli's Vision and Mission

Founded with the mission to merge technological innovation with medical expertise, Qoli seeks to redefine how micro-surgery is practiced around the world. The company's strategic focus includes not just the development and commercialization of micro-surgery supporting robots, but also ensuring their practical application in the medical field. By fostering sustainable medical systems through their innovative robotic solutions, Qoli represents a significant evolution in surgical practices.

A Future of Sustainable Healthcare

Qoli’s commitment extends beyond the mere enhancement of surgical procedures; it also addresses the sustainability of healthcare systems. By making micro-surgery operations safer and more accessible, Qoli is poised to impact countless lives positively. This strategic funding will help in scaling operations, further refining their robotic technologies, and establishing robust partnerships in the healthcare industry.

As Qoli embarks on this ambitious journey, the collaboration with industry leaders such as Sony Group allows them to harness cutting-edge technology, ensuring that their innovations are at the forefront of surgical advancements. The company envisions a future where complex surgeries can be performed with ease and confidence, ultimately leading to better patient outcomes and an elevated standard of medical care.

Company Overview

• - Established: October 1, 2025
• - Location: 3-6-4 Osaki, Shinagawa, Tokyo 141-0032
• - CEO: Yohei Kuroda
• - Capital: 909 million yen
• - Business Focus: Development, manufacturing, sales, and support of micro-surgery assisting robots and related products.
• - Official Website: Qoli Inc.

In summary, Qoli's recent funding highlights a promising future for micro-surgery, fostering technological advancements that could revolutionize surgical practices globally. The company's innovative approach not only aims to enhance the efficacy of surgical procedures but also strives to elevate the overall quality of life for patients worldwide.